Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer. [electronic resource]
Producer: 20161013Description: 77-93 p. digitalISSN:- 1932-7420
- Animals
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor -- blood
- Body Mass Index
- Cell Line, Tumor
- Colorectal Neoplasms -- blood
- Humans
- Kaplan-Meier Estimate
- Leptin -- pharmacology
- Melanoma, Experimental -- blood
- Mice
- Mice, Obese
- Proportional Hazards Models
- Quinazolines -- pharmacology
- Retrospective Studies
- Transcriptome
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.